© 1999 Oxford University Press
Article |
Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model
1 Chemoprevention Center, University of Alabama at Birmingham, 1675 University Boulevard, Birmingham, AL 35294,
2 National Cancer Institute, Division of Cancer Prevention, Bethesda, MD 20892 and
3 University of Florida, Department of Comparative and Experimental Pathology, Gainesville, FL 32610, USA
These studies examined whether the small to moderate reductions in body weight gain (
15%) affect mammary carcinogenesis. Beginning 1 week prior to methylnitrosourea (MNU) administration (experiment 1), rats received diets supplemented with 4-hydroxyphenylretinamide (4-HPR) (782 mg/kg of diet) and retinyl acetate (328 mg/kg of diet) or underwent food restrictions. Rats were administered an i.v. dose of MNU (50 mg/kg body wt) at 50 days of age. Although the final body weights were similarly depressed by 4-HPR (8%) and by retinyl acetate (11%) from rats fed ad libitum, the kinetics of inhibition were quite different. Whereas 4-HPR caused an acute decrease in body weight at the time it was administered, the effect of retinyl acetate was more chronic. At 110 days after the administration of MNU, the average number of mammary cancers per rat was 4.9 for rats fed ad libitum, 1.3 for rats fed 4-HPR, 3.1 when body weights were matched to 4-HPR-treated rats, 1.9 for retinyl acetate and 3.2 when body weights were matched to retinyl acetate. Experiment II was performed to determine the minimal degree of acute body weight gain reduction that would alter MNU-induced mammary carcinogenesis. Body weight gain depressions of 3, 6, 9, 12 and 15% were initiated at 43 days of age by dietary restrictions and MNU was administered at 50 days of age. At 120 days after MNU, the percentage decreases in mammary cancer multiplicity in the various groups were 14, 15, 41, 44 and 55%, respectively. These data demonstrate that moderate reductions (9–15%) in body weight gain, in particular when occurring during the initiation and early promotion stages can greatly affect cancer multiplicity.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Malewicz, Z. Wang, C. Jiang, J. Guo, M. P. Cleary, J. P. Grande, and J. Lu Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements Carcinogenesis, September 1, 2006; 27(9): 1739 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Watanabe, Y. Kashida, M. Ueda, H. Onodera, T. Takizawa, M. Hirose, and K. Mitsumori Inhibition by Ethinylestradiol of N-Ethyl-N-Nitrosourea-Initiated Uterine Carcinogenesis in Transgenic Mice Carrying a Human Prototype C-Ha-ras Gene (rasH2 Mice) Toxicol Pathol, August 1, 2003; 31(5): 496 - 505. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Zou, A.-T. Vlastos, L. Yang, J. Wang, M. Brewer, and M. Follen Effect of 4-Hydroxyphenylretinamide on Human Cervical Epithelial and Cancer Cell Lines Reproductive Sciences, January 1, 2003; 10(1): 41 - 48. [Abstract] [PDF]
|
|
|
|
 |
|
 T. R. Sutter, X.-R. He, P. Dimitrov, L. Xu, G. Narasimhan, E. O. George, C. H. Sutter, C. Grubbs, R. Savory, M. Stephan-Gueldner, et al. Multiple Comparisons Model-based Clustering and Ternary Pattern Tree Numerical Display of Gene Response to Treatment: Procedure and Application to the Preclinical Evaluation of Chemopreventive Agents Mol. Cancer Ther., December 1, 2002; 1(14): 1283 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Murata and S. Kawanishi Oxidative DNA Damage by Vitamin A and Its Derivative via Superoxide Generation J. Biol. Chem., January 21, 2000; 275(3): 2003 - 2008. [Abstract] [Full Text] [PDF]
|
|